Background illustration for clinical trials search

Paid Clinical Trials Detroit

Discover 1,723 paid clinical trials in Detroit, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo

for
Acne Vulgaris
Location: Clinton Township MI, Louisville KY, Woodbury NY,
Sponsor: Bausch Health Americas, Inc.

Sex: All

Age: 9 - 11

Code: NCT07524946

Recruiting

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

for
Atrial Fibrillation (AF)
Location: Farmington Hills MI, Flint MI, Maumee OH, Marion OH,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07175428

Phase 2, Recruiting

Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer

for
Locoregional Recurrence,
Location: Ann Arbor MI, Fort Wayne IN, Columbus OH, Chicago IL,
Sponsor: Oana Danciu

Sex: All

Age: 18+

Code: NCT05467891

Phase 2, Recruiting

Combination Therapy for the Treatment of Diffuse Midline Gliomas

for
Diffuse Intrinsic Pontine Glioma,
Location: Ann Arbor MI, Columbus OH, Chicago IL, Indianapolis IN,
Sponsor: University of California, San Francisco

Sex: All

Age: 2 - 39

Code: NCT05009992

Phase 2, Recruiting

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

for
Atrial Fibrillation (AF)
Location: Farmington Hills MI, Bloomfield Hills MI, Flint MI,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07430956

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

for
Atrial Fibrillation (AF)
Location: Farmington Hills MI, Bloomfield Hills MI, Flint MI,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07626411

Phase 3, Recruiting

A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events

for
Atherosclerosis
Location: Farmington Hills MI, Bloomfield Hills MI, Flint MI,
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT07448038

Phase 2, Recruiting

A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)

for
Sarcoma,Soft Tissue
Location: Farmington Hills MI, Columbus OH, Toronto,
Sponsor: Intensity Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06263231

Phase 3, Recruiting

ALTO-207 in Adults With Treatment-resistant Depression (TRD)

for
Treatment-resistant Depression (TRD)
Location: Bloomfield Hills MI, Ann Arbor MI, Garfield Heights OH,
Sponsor: Alto Neuroscience

Sex: All

Age: 18 - 70+

Code: NCT07553637

Phase 2, Recruiting

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

for
Age-related Macular Degeneration (AMD), Geographic Atrophy (GA)
Location: Grand Blanc MI, Cleveland OH, Erie PA, Dublin OH,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 50 - 70+

Code: NCT06541704

Phase 3, Recruiting

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

for
Relapsing Multiple Sclerosis
Location: Farmington Hills MI, Miami FL, Owosso MI, Cleveland OH,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 40 - 70

Code: NCT06846281

Phase 3, Recruiting

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

for
Secondary Progressive Multiple Sclerosis (SPMS)
Location: Farmington Hills MI, Cleveland OH, Chicago IL,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT07225504

Phase 3, Recruiting

Optimizing Reperfusion to Improve Outcomes and Neurologic Function

for
Acute Ischemic Stroke
Location: Toledo OH, Kalamazoo MI, Columbus OH, Traverse City MI,
Sponsor: Corxel Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06990867

Phase 2, Phase 3, Recruiting

A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years

for
Multiple Sclerosis
Location: Farmington Hills MI, St Louis MO, Oklahoma City OK,
Sponsor: ModernaTX, Inc.

Sex: All

Age: 18 - 55

Code: NCT06735248

Phase 2, Recruiting

A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

for
Parkinsons Disease (PD)
Location: Farmington Hills MI, Ann Arbor MI, Toledo OH, Toronto,
Sponsor: BlueRock Therapeutics

Sex: All

Age: 45 - 70+

Code: NCT06944522

Phase 3, Recruiting

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

for
Alzheimer's Disease
Location: Farmington Hills MI, Amherst NY, Buffalo NY,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 60 - 70+

Code: NCT06976203

Phase 3, Recruiting

Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease

for
Parkinson Disease
Location: Farmington Hills MI, New York NY, Gainesville FL,
Sponsor: Hillhurst Biopharmaceuticals, Inc.

Sex: All

Age: 40 - 70+

Code: NCT07005180

Phase 2, Recruiting

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

for
Alzheimers Disease
Location: Farmington Hills MI, London, Columbus OH, Toronto,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 50 - 70+

Code: NCT07177352

Phase 3, Recruiting

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Ann Arbor MI, Cleveland OH, Battle Creek MI, Akron OH,
Sponsor: Children's Oncology Group

Sex: Female

Age: 0 - 39

Code: NCT06513962

Phase 3, Recruiting

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

for
Parkinson's Disease
Location: Farmington Hills MI, Cleveland OH, Canton OH,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 50 - 70+

Code: NCT07174310

Phase 3, Recruiting